1 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
First-line Immunotherapy-based Standard of Care and Local Ablative Treatments for Oligometastatic Non-small Cell Lung Cancer Patients.Oligometastatic Non-small Cell Lung Cancer (NSCLC)RecruitingPhase 32025-09-15NCT06840782